| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/13/2011 | EP2343085A2 Antibody against prostate stem cell antigen (PSCA) |
| 07/13/2011 | EP2343084A1 Functional influenza virus-like particles (VLP) |
| 07/13/2011 | EP2343083A2 Method of selecting patients suitable for WT1 vaccine |
| 07/13/2011 | EP2343052A1 Hydrophilic filtration during manufacture of vaccine adjuvants |
| 07/13/2011 | EP2342568A1 Cadherin-17 as diagnostic marker and therapeutic target for liver cancer |
| 07/13/2011 | EP2342230A1 Materials and methods for inhibiting cancer cell invasion related to fgfr4 |
| 07/13/2011 | EP2342229A1 Pd-1 specific antibodies and uses thereof |
| 07/13/2011 | EP2342228A1 Pd-1 specific antibodies and uses thereof |
| 07/13/2011 | EP2342226A2 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor |
| 07/13/2011 | EP2342220A1 Methods and systems for predicting misfolded protein epitopes |
| 07/13/2011 | EP2342219A1 Immunogenic peptides |
| 07/13/2011 | EP2342215A1 Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease |
| 07/13/2011 | EP2341940A1 The stabilisation of proteins |
| 07/13/2011 | EP2341937A1 Composition for treating disease |
| 07/13/2011 | EP2341936A1 METHODS FOR TREATING OR PREVENTING IL-1ß RELATED DISEASES |
| 07/13/2011 | EP2341935A1 Methods for improvement of beta cell function |
| 07/13/2011 | EP2341934A2 Methods to reduce b-helper t cells to treat autoimmune diseases |
| 07/13/2011 | EP2341933A1 Lipidated imidazoquinoline derivatives |
| 07/13/2011 | EP2341932A1 High-energy pulsed electric field vaccine adjuvants |
| 07/13/2011 | EP2341931A1 Vaccine composition for use against influenza |
| 07/13/2011 | EP2341930A1 Outer membrane vesicle prime - protein boost vaccine |
| 07/13/2011 | EP2341929A1 Compositions and methods related to bacterial eap, emp, and/or adsa proteins |
| 07/13/2011 | EP2341928A1 Mycobacterium tuberculosis vaccine |
| 07/13/2011 | EP2341927A2 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 07/13/2011 | EP2341926A1 Method for purifying protein complexes |
| 07/13/2011 | EP2341908A1 Individual 5-fluorouracile dose optimization in folfiri treatment |
| 07/13/2011 | EP2341897A2 Nanoparticles for immunotherapy |
| 07/13/2011 | EP2143438B1 Compositions and methods for the diagnosis and treatment of tumors |
| 07/13/2011 | EP1904626B1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications |
| 07/13/2011 | EP1863526B1 Live attenuated rotavirus vaccine for oral administration |
| 07/13/2011 | EP1828247B1 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 07/13/2011 | EP1765398B1 Human antibodies interacting with hiv gp41 |
| 07/13/2011 | EP1765312B1 Treatment of diseases associated with the use of antibiotics |
| 07/13/2011 | EP1633784B1 Ovr110 antibody compositions and methods of use |
| 07/13/2011 | EP1624890B1 Identification of vaccinia virus dominant t cell epitopes |
| 07/13/2011 | EP1543039B1 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | EP1178825B1 Adjuvant combination formulations |
| 07/13/2011 | EP0979080B1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/13/2011 | CN1922309B A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/13/2011 | CN102124105A Antibody capable of binding specifically to Abeta-oligomer, and use thereof |
| 07/13/2011 | CN102124029A Method of diagnosis of infection by mycobacteria and reagents therefor |
| 07/13/2011 | CN102123734A Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells |
| 07/13/2011 | CN102123733A Composition comprising a complexed (m)RNA and a naked (m)RNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| 07/13/2011 | CN102123732A Compositions, methods and kits for eliciting an immune response |
| 07/13/2011 | CN102123731A Immunogenic peptides derived from the midkine protein, as an anticancer vaccine |
| 07/13/2011 | CN102123724A Compositions and methods for treating influenza |
| 07/13/2011 | CN102123712A Methods of cancer treatment with IGF1R inhibitors |
| 07/13/2011 | CN102123698A Carrier nanoparticles and related compositions, methods and systems |
| 07/13/2011 | CN102121021A cDNA of interferon (IFN)-gamma inducible lysosomal thiol reductase of sheep, cloning method and recombinant application thereof |
| 07/13/2011 | CN102121012A Dog B lymphocyte activating factor cDNA, cloning method and recombination application thereof |
| 07/13/2011 | CN102120988A Recombinant porcine circovirus type 2 strain expressing V5 epitope tag and application thereof |
| 07/13/2011 | CN102120987A Construction of four different sub-genotypes of porcine circovirus type 2 molecular cloning strains and application thereof |
| 07/13/2011 | CN102120773A Dual specificity antibodies and methods of making and using |
| 07/13/2011 | CN102120759A Polypeptide as well as derivatives and application thereof |
| 07/13/2011 | CN102120029A Preparation method of alginate microparticles capable of inducing tumor immune response |
| 07/13/2011 | CN102120028A Method for extracting lipopolysaccharides from avian pasteurella multocida and preparing lipopolysaccharide vaccine |
| 07/13/2011 | CN101525602B Polypeptide for preparing anti-PINK1 polyclonal antiserum and application thereof |
| 07/13/2011 | CN101098704B Method of removing leukocyte |
| 07/12/2011 | US7977465 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 07/12/2011 | US7977464 Antibody molecules specific to human tumour necrosis factor alpha |
| 07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
| 07/12/2011 | US7977314 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| 07/12/2011 | US7977071 Binding moieties based on shark ignar domains |
| 07/12/2011 | US7977062 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 07/12/2011 | US7977058 Diagnostic method for atherosclerosis |
| 07/12/2011 | US7977047 Delete sequence in M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 07/12/2011 | US7976868 Liposomes comprising duramycin and anti-viral agents |
| 07/12/2011 | US7976851 Non-toxic biofilm inhibitor |
| 07/12/2011 | US7976850 Pox viridae treatment |
| 07/12/2011 | US7976849 Hepatitis-C virus testing |
| 07/12/2011 | US7976848 Optimized expression of HPV 58 L1 in yeast |
| 07/12/2011 | US7976846 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor |
| 07/12/2011 | US7976845 Viral protein for use as tool in developing vaccines for prevention and treatment of viral infection |
| 07/12/2011 | US7976844 Fusion proteins of Mycobacterium tuberculosis |
| 07/12/2011 | US7976843 Method for screening peptides for use in immunotherapy |
| 07/12/2011 | US7976842 Treatment of metastatic breast cancer |
| 07/12/2011 | US7976841 Anti TfR antibody |
| 07/12/2011 | US7976840 Use of anti-GL50 antibodies for the downmodulation of an immune response |
| 07/12/2011 | US7976839 Growth differentiation factor-11 |
| 07/12/2011 | US7976838 Therapy of autoimmune disease in a patient with an inadequate response to a TNF-α inhibitor |
| 07/12/2011 | US7975690 Nasal devices |
| 07/12/2011 | CA2562738C Soluble rubella e1 envelope antigens |
| 07/12/2011 | CA2506318C Unexpected surface proteins in neisseria meningitidis |
| 07/12/2011 | CA2497167C Modified saccharides, conjugates thereof, and their manufacture |
| 07/12/2011 | CA2486738C Method for identifying immunoreactive peptides |
| 07/12/2011 | CA2480162C Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40 |
| 07/12/2011 | CA2468957C Methods of propagation of influenza virus in cell lines over expressing sialyl transferases |
| 07/12/2011 | CA2463616C Affinity enhancement agents |
| 07/12/2011 | CA2440610C Induction of tumor immunity by variants of folate binding protein |
| 07/12/2011 | CA2421575C Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 07/12/2011 | CA2419148C Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 07/12/2011 | CA2415348C Isolated polynucleotide sequences encoding a fertility associated antigen |
| 07/12/2011 | CA2405438C Hepatitis b core antigen fusion proteins |
| 07/12/2011 | CA2396744C Synthetic lipid-a analogs and uses thereof |
| 07/12/2011 | CA2329133C Recombinant venezuelan equine encephalitis virus vaccine |
| 07/12/2011 | CA2220442C Chromatin regulator genes |
| 07/12/2011 | CA2182976C Active immunization using a siderophore receptor protein |
| 07/12/2011 | CA2162555C Method for the culture in vitro of different stages of tissue parasites |
| 07/12/2011 | CA2162262C Methods for treating muscle diseases and disorders |